Correlation Between Edgewise Therapeutics and Nova Mentis
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Nova Mentis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Nova Mentis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Nova Mentis Life, you can compare the effects of market volatilities on Edgewise Therapeutics and Nova Mentis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Nova Mentis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Nova Mentis.
Diversification Opportunities for Edgewise Therapeutics and Nova Mentis
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Edgewise and Nova is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Nova Mentis Life in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nova Mentis Life and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Nova Mentis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nova Mentis Life has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Nova Mentis go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Nova Mentis
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Nova Mentis. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 6.14 times less risky than Nova Mentis. The stock trades about -0.05 of its potential returns per unit of risk. The Nova Mentis Life is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 3.20 in Nova Mentis Life on September 23, 2024 and sell it today you would lose (0.95) from holding Nova Mentis Life or give up 29.69% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Edgewise Therapeutics vs. Nova Mentis Life
Performance |
Timeline |
Edgewise Therapeutics |
Nova Mentis Life |
Edgewise Therapeutics and Nova Mentis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and Nova Mentis
The main advantage of trading using opposite Edgewise Therapeutics and Nova Mentis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Nova Mentis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nova Mentis will offset losses from the drop in Nova Mentis' long position.Edgewise Therapeutics vs. Fate Therapeutics | Edgewise Therapeutics vs. Sana Biotechnology | Edgewise Therapeutics vs. Caribou Biosciences | Edgewise Therapeutics vs. Arcus Biosciences |
Nova Mentis vs. PsyBio Therapeutics Corp | Nova Mentis vs. HAVN Life Sciences | Nova Mentis vs. TC BioPharm plc | Nova Mentis vs. Opthea |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |